2017
DOI: 10.5009/gnl15502
|View full text |Cite
|
Sign up to set email alerts
|

25 Years of Proton Pump Inhibitors: A Comprehensive Review

Abstract: Proton pump inhibitors (PPIs) were clinically introduced more than 25 years ago and have since proven to be invaluable, safe, and effective agents for the management of a variety of acid-related disorders. Although all members in this class act in a similar fashion, inhibiting active parietal cell acid secretion, there are slight differences among PPIs relating to their pharmacokinetic properties, metabolism, and Food and Drug Administration (FDA)-approved clinical indications. Nevertheless, each is effective … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
388
1
34

Year Published

2018
2018
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 451 publications
(471 citation statements)
references
References 94 publications
2
388
1
34
Order By: Relevance
“…Proton pump inhibitors are widely used for the management of peptic ulcer disease, gastroesophageal reflux disease and eradication of Helicobacter pylori infection 5. However, its safety for long-term use has raised pubic concern 6.…”
mentioning
confidence: 99%
“…Proton pump inhibitors are widely used for the management of peptic ulcer disease, gastroesophageal reflux disease and eradication of Helicobacter pylori infection 5. However, its safety for long-term use has raised pubic concern 6.…”
mentioning
confidence: 99%
“…Interestingly, it has been shown repeatedly that more than half of their use is without any clear indication, and often for prolonged periods of time. This misuse, besides subjecting patients to potential adverse effects, poses a significant financial burden for the healthcare system …”
Section: Proton Pump Inhibitorsmentioning
confidence: 99%
“…Patients who fail to comply to diet changes often prefer medications. Since the initial release in the late 1980s of omeprazole, proton pump inhibitors (PPIs) have dominated the global medication market . According to the package insert, they are indicated for GERD, peptic ulcer disease (PUD), GI bleeding, and in patients taking long‐term non‐steroidal anti‐inflammatory drugs (NSAIDs) .…”
Section: Introductionmentioning
confidence: 99%
“…5,6 Gastro-oesophageal reflux is a common medical problem associated with reflux movement of gastric contents into the oesophagus can cause a varying range of symptoms, from hiccups and burp to pain and physical discomfort. 7 As of 2016, there are six PPIs approved by the United States Food and Drug Administration (FDA) 8 and DCGI in India. …”
Section: Introductionmentioning
confidence: 99%